Dishman Carbogen Amcis shareholders approve all five AGM resolutions

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Dishman Carbogen Amcis Limited passed all five resolutions at its 19th AGM held on September 30, 2026
  • Shareholders approved the adoption of standalone and consolidated financial statements for FY26
  • Re-appointment of Arpit J. Vyas as director and T R Chadha & Co. LLP as auditors secured majority support
  • Auditor re-appointment resolution saw 58,544 votes against, the highest dissent among all agenda items
powered bylight_fuzz_icon
52384127

*this image is generated using AI for illustrative purposes only.

Dishman Carbogen Amcis Limited concluded its 19th Annual General Meeting on September 30, 2026, with all five proposed resolutions passed by shareholders. The meeting, conducted via video conferencing, saw robust voting participation across promoter and public categories.

The agenda included the adoption of audited standalone and consolidated financial statements for FY26, along with the re-appointment of a director and statutory auditors. All ordinary and special resolutions received overwhelming support, reflecting shareholder confidence in the company's governance and operational direction.

Voting participation and attendance

A total of 58 participants attended the meeting through video conferencing, comprising five from the promoter group and 53 public shareholders. No shareholders attended in person or through proxy. The record date for determining entitlement to vote was September 23, 2026, with 50,113 shareholders on the register.

Voting was conducted exclusively through remote e-voting. Promoter and promoter group members voted on 93,002,442 shares, representing 99.99% of their holdings. Public institutions participated significantly, voting on approximately 88.4% of their held shares for most resolutions.

Resolution outcomes

All five resolutions were passed with substantial majorities. The table below summarizes the key voting results for each agenda item:

Resolution Description Votes In Favour Votes Against Result
1(a) Adoption of Standalone Financial Statements (FY26) 106,119,651 5,806 Passed
1(b) Adoption of Consolidated Financial Statements (FY26) 106,176,240 5,806 Passed
2 Re-appointment of Director Arpit J. Vyas 106,175,535 6,511 Passed
3 Re-appointment of T R Chadha & Co. LLP as Auditors 106,123,502 58,544 Passed
4 Payment of Remuneration to Non-Executive Directors 102,284,158 7,678 Passed

What the numbers show

While all resolutions passed comfortably, the re-appointment of statutory auditors T R Chadha & Co. LLP attracted the highest number of dissenting votes among public shareholders. Public institutions cast 52,233 votes against this resolution, contributing to a total of 58,544 votes against out of 106,182,046 polled. This represents 0.05% opposition, still well within the majority threshold but notably higher than the negligible dissent seen on other items like financial statement adoption or director re-appointment.

Additionally, nine shareholders holding 3,890,210 equity shares abstained from voting on the remuneration resolution (Resolution 4), indicating a segment of institutional investors may have had reservations regarding the proposed commission structure for non-executive directors.

Historical Stock Returns for Dishman Carbogen Amcis

1 Day5 Days1 Month6 Months1 Year5 Years
-4.52%-13.26%-13.97%+15.68%-45.45%-24.83%

Will the slight increase in dissenting votes regarding the auditor's re-appointment prompt Dishman Carbogen Amcis to review its audit committee policies or consider alternative auditors in the next cycle?

How might the abstentions by institutional investors on the non-executive director remuneration resolution influence the board's approach to future compensation proposals?

What specific operational or strategic milestones does the company plan to prioritize in FY27 following the reaffirmed shareholder confidence in its current governance structure?

like20
dislike

Dishman Carbogen Allots ₹15 Crore NCDs on Private Placement Basis

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Dishman Carbogen Amcis Ltd allotted 1,500 NCDs aggregating ₹15 crore on September 28, 2026
  • The debentures have a face value of ₹1 lakh each and were issued at par via private placement
  • Final maturity date for the instrument is set for March 28, 2028, or an early redemption date
  • This allotment is part of a larger ₹150 crore NCD issue framework approved by the Board in March 2026
powered bylight_fuzz_icon
52123982

*this image is generated using AI for illustrative purposes only.

Dishman Carbogen Amcis Limited has allotted 1,500 Senior, Secured, Rated, Listed, Redeemable, Transferable, Taxable Non-Convertible Debentures (NCDs) aggregating ₹15 crore through a private placement. The allotment was approved by the Management Committee of the Board of Directors on September 28, 2026.

The debentures were issued at par for cash, with a face value of ₹1 lakh each. This issuance is part of a broader board-approved plan to raise up to ₹150 crore via NCDs, as outlined in earlier disclosures from March 2026. The securities are listed and rated, offering investors a secured debt instrument with a fixed maturity profile.

Key Allotment Details

The following table summarizes the specific terms of the allotment:

Parameter Details
Date of Allotment September 28, 2026
Number of Debentures 1,500
Face Value ₹1 lakh each
Total Amount ₹15 crore
Type Senior, Secured, Rated, Listed, Redeemable, Transferable, Taxable NCDs
Maturity Date March 28, 2028 (or any Early Redemption Date)
Issue Mode Private Placement

Regulatory Compliance and Timeline

The allotment was executed in compliance with Regulations 30, 51, and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Management Committee meeting commenced at 11:40 am and concluded at 12:10 pm on the date of allotment.

The issue terms were governed by the General Information Document dated December 30, 2025, and the Key Information Document dated September 24, 2026. The company had previously intimated the stock exchanges regarding the Board's approval of the NCD issue framework in March 2026.

What the Numbers Show

The current allotment of ₹15 crore represents 10% of the total ₹150 crore borrowing limit approved by the Board in March 2026. This indicates a phased approach to debt raising, where the company is tapping into its approved capital structure incrementally rather than executing the full quantum at once. With a tenor of approximately 18 months (September 2026 to March 2028), this tranche adds medium-term secured liabilities to the balance sheet, likely aligned with near-term working capital or capital expenditure requirements.

Historical Stock Returns for Dishman Carbogen Amcis

1 Day5 Days1 Month6 Months1 Year5 Years
-4.52%-13.26%-13.97%+15.68%-45.45%-24.83%

How will the phased debt raising strategy impact Dishman Carbogen Amcis's weighted average cost of capital as interest rate volatility continues?

What specific capital expenditure or working capital projects are being funded by this initial ₹15 crore tranche of the ₹150 crore NCD program?

How does the current credit rating assigned to these senior secured debentures compare to the company's previous debt instruments, and what factors influenced the rating agency's decision?

like18
dislike

More News on Dishman Carbogen Amcis

1 Year Returns:-45.45%